Cargando…
SPARC: A Potential Prognostic and Therapeutic Target in Pancreatic Cancer
Pancreatic cancer is a complex and heterogeneous disease that often lacks disease-specific symptoms in early stages. The malignancy is currently the fourth leading cause of cancer-related death in Western countries. In advanced stages, the overall 5-year survival is less than 1% to 2%. Most availabl...
Autores principales: | Vaz, Juan, Ansari, Daniel, Sasor, Agata, Andersson, Roland |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4568900/ https://www.ncbi.nlm.nih.gov/pubmed/26335014 http://dx.doi.org/10.1097/MPA.0000000000000409 |
Ejemplares similares
-
Histone profiling reveals the H1.3 histone variant as a prognostic biomarker for pancreatic ductal adenocarcinoma
por: Bauden, Monika, et al.
Publicado: (2017) -
The role of quantitative mass spectrometry in the discovery of pancreatic cancer biomarkers for translational science
por: Ansari, Daniel, et al.
Publicado: (2014) -
Calcium-activated chloride channel regulator 1 as a prognostic biomarker in pancreatic ductal adenocarcinoma
por: Hu, Dingyuan, et al.
Publicado: (2018) -
Outcome and evaluation of prognostic factors after pancreaticoduodenectomy for distal cholangiocarcinoma
por: Byrling, Johannes, et al.
Publicado: (2017) -
Stromal fibronectin expression in patients with resected pancreatic ductal adenocarcinoma
por: Hu, Dingyuan, et al.
Publicado: (2019)